340B Program

The 340B program allows qualifying safety net providers that serve a high proportion of low-income, uninsured, and underinsured patients to purchase outpatient drugs at a discounted price from pharmaceutical manufacturers. GNYHA continues to educate lawmakers on the importance of the 340B program, and will keep members informed on program updates.

9 Items in 340B Program
SCOTUS to Hear AHA Challenge to 340B Rate Cut, Declines to Hear Challenge to Site-Neutral Cut
July 2, 2021
News
Finance & Insurance Medicare 340B Program
Finance Icon
CMS Proposes Additional 340B Drug Cuts, Makes Certain Telehealth Provisions Permanent, and Responds to Allina Ruling
August 6, 2020
News
Finance & Insurance Medicare 340B Program
Finance Icon
Proposed Collection of 340B Acquisition Cost Data Under OMB Review
February 18, 2020
News
Finance & Insurance Medicare 340B Program
Finance Icon
GAO Recommends Increased Oversight of 340B Program
February 18, 2020
News
Finance & Insurance Medicare 340B Program
Finance Icon
GNYHA Opposes Survey of 340B Drug Acquisition Costs
December 16, 2019
News
Finance & Insurance Medicare 340B Program
Finance Icon
CMS Proposes to Collect 340B Acquisition Cost Data
October 2, 2019
News
Finance & Insurance Medicare 340B Program
Finance Icon
2019 Payment Rates for Drugs Subject to the 340B Cuts
November 30, 2018
Data
Finance & Insurance Medicare 340B Program
Finance Icon
Claim-Level Calculator for Appeals Related to 340B Payment Cuts
April 6, 2018
Data
Finance & Insurance Medicare 340B Program
Finance Icon
340B Update: Preserve Your Appeal Rights
April 6, 2018
News
Finance & Insurance Medicare 340B Program
Finance Icon